1992
DOI: 10.1159/000126299
|View full text |Cite
|
Sign up to set email alerts
|

α<sub>2</sub>-Adrenergic Receptors Are Involved in the Suppression of Luteinizing Hormone Release during Acute Fasting in the Ovariectomized Estradiol-Primed Rats

Abstract: It has been previously reported that the adrenergic system is involved in the control of feeding behavior and LH release. In the present study, the role of the adrenergic receptors in the suppression of LH release during acute fasting are examined by injecting the α2-antagonist (prazosin), β-antagonists (idazoxan, SKF 86466-A, piperoxan), or β-antagonist (propranolol) into the third ventricle of unfasted and 48 h fasted ovariectomized estradiol-treated rats. Blood samples were collected every 6 min … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
1

Year Published

1996
1996
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 32 publications
(16 citation statements)
references
References 21 publications
1
13
1
Order By: Relevance
“…Similarly, female NPY KO mice do not exhibit a suppression of LH levels after a fast (100), but we are not aware of any comparable data with DBH KO mice. Although these findings seem to indicate an essential role for NPY, it has also been reported that ICV administration of ␣-adrenergic antagonists is sufficient to prevent fasting-induced decreases in LH levels (27), consistent with crucial participation of ␣-adrenergic transmission. Perhaps both NPY and CA signaling are required.…”
Section: Control Of Lh Secretionmentioning
confidence: 77%
See 2 more Smart Citations
“…Similarly, female NPY KO mice do not exhibit a suppression of LH levels after a fast (100), but we are not aware of any comparable data with DBH KO mice. Although these findings seem to indicate an essential role for NPY, it has also been reported that ICV administration of ␣-adrenergic antagonists is sufficient to prevent fasting-induced decreases in LH levels (27), consistent with crucial participation of ␣-adrenergic transmission. Perhaps both NPY and CA signaling are required.…”
Section: Control Of Lh Secretionmentioning
confidence: 77%
“…2) Energetic challenges such as food deprivation and diabetes increase release of NE and NPY in the forebrain (3,118,153,160,195,231). 3) Forebrain infusions of either NPY (30,177) or NE (27,241) inhibit LH secretion (Figs. 7 and 8), and studies using selective agonists and antagonists suggest that these effects are mediated by NPY Y5 and ␣-adrenergic receptors, respectively (27,177).…”
Section: Control Of Lh Secretionmentioning
confidence: 99%
See 1 more Smart Citation
“…The neural pathways that relay information on insufficient energy stores to GnRH neurons included many signals. Different neuropeptides and neurotransmitters [such as NPY, adrenaline via ␣ 2 -adrenergic receptors, corticotropinreleasing hormone (CRH), leptin, ciliary neurotropic factor (CNTF), ␥-aminobutyric acid, and opioids] have been implicated in the effects of fasting on pituitary secretion (8,32,38,39,40,44).…”
Section: Discussionmentioning
confidence: 99%
“…The MA dose (2 μmol/rat) has previously been shown to suppress LH pulses, when injected into the 4V [13]. In addition, the dose for PVN injection was one third of the dose for intracerebroventricular injection of the α1-, α2-or β-adrenergic antagonist to block fasting-induced suppression of LH pulses [16] in E2-implanted ovariectommized rats. This treatment regimen resulted in the following eight groups: PVN vehicle+4V MA (n=6); PVN α1-antagonist+4V MA (n=5); PVN α2-antagonist+4V MA (n=5); PVN β-antagonist+4V MA (n=6); PVN vehicle+4V Saline (n=5); PVN α1-antagonist+4V saline (n=5); PVN α2-antagonist+4V saline (n=5); and PVN β-antagonist+4V saline (n=5).…”
Section: Drug Administration and Blood Samplingmentioning
confidence: 99%